Dermatology · Springfield, MA
NPI
1619977402
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
125 Liberty St, Ste 403
Springfield, MA, 01103
Phone (413) 739-6611
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
503 services
Medicare patients, 2024
165
Average age 71
Drug cost, 2024
$5.3M
8,070 prescriptions
Company payments, 2025
$199
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter T Demos was code 17003 (destruction skin lesion), 228 times for 37 patients. In total Peter T Demos billed 503 services in 17 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 228 | 37 | $4.65 | $1,059 |
| 99213 Office E&M - Established | Office | 104 | 101 | $53.70 | $5,585 |
| 17000 Destruction Skin Lesion | Office | 48 | 48 | $45.34 | $2,176 |
| 99203 Office E&M - New | Office | 29 | 29 | $71.86 | $2,084 |
| 99214 Office E&M - Established | Office | 25 | 25 | $89.42 | $2,236 |
| 11102 Skin Biopsy | Office | 19 | 19 | $70.38 | $1,337 |
| 17110 Destruction Skin Lesion | Office | 18 | 18 | $76.50 | $1,377 |
By year: 2022 $164K for 3,426 services; 2023 $11K for 300 services; 2024 $18K for 503 services.
Medicare prescription drug claims, 2024
In 2024, the drug Peter T Demos prescribed most often to Medicare patients was Triamcinolone Acetonide, with 966 prescriptions and refills. In total Peter T Demos wrote 8,070 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 966 | 1,052 | 457 | $15K |
| Ketoconazole Generic | 915 | 1,003 | 363 | $17K |
| Betamethasone Dipropionate Generic | 494 | 525 | 276 | $24K |
| Hydrocortisone Generic | 482 | 550 | 280 | $6,434 |
| Tacrolimus Generic | 459 | 473 | 220 | $50K |
| Fluocinonide Generic | 340 | 386 | 175 | $12K |
| Ammonium Lactate Generic | 290 | 315 | 120 | $7,325 |
| Clobetasol Propionate Generic | 269 | 284 | 132 | $12K |
| Doxycycline Monohydrate Generic | 251 | 276 | 116 | $5,409 |
| Metronidazole Generic | 223 | 267 | 116 | $7,857 |
| Hydroxyzine Hcl Generic | 219 | 290 | 66 | $3,247 |
| Clindamycin Phosphate Generic | 210 | 222 | 81 | $5,668 |
| Alclometasone Dipropionate Generic | 191 | 196 | 99 | $6,775 |
| Dupixent Pen Dupilumab | 182 | 182 | 29 | $679K |
| Calcipotriene Generic | 128 | 131 | 67 | $14K |
Brand drugs: 1,205 claims; generic drugs: 6,865 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter T Demos $199 ($199 in general payments such as food, travel and fees) from 6 companies. The largest payer was Amgen Inc. with $66.46.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.